X

Drug Profile

Ketoprofen topical - Celtic Pharma

Alternative Names: TDT-070

Latest Information Update: 20 Aug 2015

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator IDEA
Developer Celtic Pharma
Class Analgesics; Anti-inflammatories
Mechanism of Action Cyclooxygenase inhibitors; Lipoxygenase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Discontinued Photodamage; Skin disorders

Most Recent Events

20 Jun 2008 Clinical development is ongoing
23 Feb 2006 IDEA 070 has been licensed to Celtic Pharma worldwide
18 Mar 2005 Data presented at the 63rd Annual Meeting of the American Academy of Dermatology (AAD-2005) have been added to the adverse events and Skin disorders therapeutic trials sections

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com